Novel inhibitory effects of dotinurad, a selective urate reabsorption inhibitor, on urate crystal-induced activation of NLRP3 inflammasomes in macrophages
Authors:
- Peili LiPLPeili Li
- Masanari KuwabaraMasanari Kuwabara
- Yasutaka KurataYKYasutaka Kurata
- Toshihiro HamadaTHToshihiro Hamada
- Aiko TakamiATAiko Takami
- Junichiro MiakeJMJunichiro Miake
- Motokazu TsunetoMTMotokazu Tsuneto
- Kimiyoshi IchidaKimiyoshi Ichida
- Haruaki NinomiyaHNHaruaki Ninomiya
- Satoshi MiyazakiSMSatoshi Miyazaki
Open Access
- 24 April 2020
- journal article
- research article
- Published by Japan Society for Vascular Failure in Vascular Failure
- Vol. 3 (2) , 59-67
Abstract
Background:When macrophages are primed by lipopolysaccharides, mono sodium urate (MSU) crystals activate NLRP3 inflammasomes and promote IL-1β and IL-18 production after phagocytosis of MSU. It was previously reported that anti-IL-1β antibodies suppress symptoms of gout and the occurrence of cardiovascular disease. Thus, inhibition of NLRP3 inflammasomes, which produce IL-1β and IL-18, may be a novel therapeutic strategy against these diseases. Purpose:To reveal the effects of dotinurad, a selective urate reabsorption inhibitor, and other uric acid lowering agents on MSU crystal-induced activation of NLRP3 inflammasomes in macrophages. Methods:Activity of NLRP3 inflammasomes in J774 mouse macrophages was evaluated by quantifying secreted caspase-1 and IL-1β using a western blot and ELISA in both the absence and presence of dotinurad or other uric acid lowering agents. Results:MSU increased protein levels of caspase-1 and IL-1β. This effect was inhibited by a clinical concentration of dotinurad. Neither febuxostat nor allopurinol influenced the levels of caspase-1 and IL-1β, whereas benzbromarone decreased their levels. The inhibitory effects of dotinurad and other uric acid lowering agents on secretions of IL-1β from the macrophages were confirmed by ELISA. Conclusion:Dotinurad, a selective urate reabsorption inhibitor, suppresses MSU-induced activation of NLRP3 inflammasomes in macrophages.Keywords
This publication has 38 references indexed in Scilit:
- Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial FibrillationCirculation, 2018
- Elevated Serum Uric Acid Level Predicts Rapid Decline in Kidney FunctionAmerican Journal of Nephrology, 2017
- Inflammation as a link between obesity, metabolic syndrome and type 2 diabetesDiabetes Research and Clinical Practice, 2014
- Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasomeNature Immunology, 2013
- Japanese Guideline for the Management of Hyperuricemia and Gout: Second EditionNucleosides, Nucleotides & Nucleic Acids, 2011
- The NLRP3 Inflammasome Promotes Renal Inflammation and Contributes to CKDJournal of the American Society of Nephrology, 2010
- High Serum Uric Acid as a Novel Risk Factor for Type 2 DiabetesDiabetes Care, 2008
- Role of uric acid in hypertension, renal disease, and metabolic syndrome.Cleveland Clinic Journal of Medicine, 2006
- Gout-associated uric acid crystals activate the NALP3 inflammasomeNature, 2006
- Prognostic Usefulness of Serum Uric Acid After Acute Myocardial Infarction (The Japanese Acute Coronary Syndrome Study)The American Journal of Cardiology, 2005